UPDATE: BofA Securities Upgrades Teva Pharma (TEVA) to Neutral

May 17, 2022 5:30 AM EDT Send to a Friend
(Updated - May 17, 2022 6:05 AM EDT)

BofA Securities analyst Jason Gerberry upgraded Teva Pharma (NYSE: TEVA) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login